1887

Abstract

A total of 24 monoclonal antibodies (MAbs) against the haemagglutinin (H) and the fusion protein (F) of rinderpest virus (RPV) were used to characterize their antigenic structure and biological properties, and to analyse natural variation in the envelope proteins of morbilliviruses. The anti-H and anti-F MAbs defined seven and three distinct antigenic sites, respectively. The MAbs to six sites on H were able to neutralize the infectivity of RPV. The addition of guinea-pig complement or anti-mouse immunoglobulin increased the virus-neutralizing antibody titre of most of the anti-H MAbs, including those lacking neutralizing activity. One of the antigenic sites on H was conserved among morbilliviruses and the MAbs to this site had haemagglutination inhibition activity against measles virus (MV). The remaining sites were specific for RPV and varied antigenically between strains of RPV. The anti-F MAbs lacked neutralizing activity, but two of the five MAbs did show activity in the presence of complement or anti-mouse immunoglobulin. On the whole, the antigenic sites on F were conserved in some strains of MV, but not in canine distemper virus. All of the sites on the surface proteins were sensitive to SDS and, although those on F were not affected by 2-mercaptoethanol, five of the seven sites on H were destroyed by it. These results suggest that the epitopes on the envelope proteins are conformation-dependent.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-72-8-1863
1991-08-01
2024-12-07
Loading full text...

Full text loading...

/deliver/fulltext/jgv/72/8/JV0720081863.html?itemId=/content/journal/jgv/10.1099/0022-1317-72-8-1863&mimeType=html&fmt=ahah

References

  1. Barrett T., Belsham G. J., Subbarao S. M., Evans S. A. 1989; Immunization with a vaccinia recombinant expressing the F protein protects rabbits from challenge with a lethal dose of rinderpest virus. Virology 170:11–18
    [Google Scholar]
  2. Belsham G. J., Anderson E. C., Murray P. K., Anderson J., Barrett T. 1989; Immune response and protection of cattle and pigs generated by a vaccinia virus recombinant expressing the F protein of rinderpest virus. Veterinary Record 124:655–658
    [Google Scholar]
  3. Bhavani K., Karande A. A., Shaila M. S. 1989; Preparation and characterization of monoclonal antibodies to nucleocapsid protein N and H glycoprotein of rinderpest virus. Virus Research 12:331–348
    [Google Scholar]
  4. Buckland R., Giraudon P., Wild F. 1989; Expression of measles virus nucleoprotein in Escherichia coli: use of deletion mutants to locate the antigenic sites. Journal of General Virology 70:435–441
    [Google Scholar]
  5. Giraudon P., Wild T. F. 1985; Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity. Virology 144:46–58
    [Google Scholar]
  6. Grubman M. J., Mebus C., Dale B., Yamanaka M., Yilma T. 1988; Analysis of the polypeptides synthesized in rinderpest virus-infected cells. Virology 163:26–267
    [Google Scholar]
  7. Homma M., Ohuchi M. 1973; Trypsin action on the growth of Sendai virus in tissue culture ceils. III. Structural differences of Sendai viruses grown in eggs and tissue culture cells. Journal of Virology 12:1457–1465
    [Google Scholar]
  8. Hsu D., Yamanaka M., Miller J., Dale B., Grubman M., Yilma T. 1988; Cloning of the fusion gene of rinderpest virus: comparative sequence analysis with other morbilliviruses. Virology 166:149–153
    [Google Scholar]
  9. Ishii H., Yoshikawa Y., Yamanouchi K. 1986; Adaptation of the lapinized rinderpest virus to in vitro growth and attenuation of its virulence in rabbits. Journal of General Virology 67:275–280
    [Google Scholar]
  10. Long L., Portetelle D., Ghysdael J., Gonze M., Burny A., Meulemans G. 1986; Monoclonal antibodies to hemagglutinin-neuraminidase and fusion glycoproteins of Newcastle disease virus: relationship between glycoprotein and reactivity. Journal of Virology 57:1198–1202
    [Google Scholar]
  11. Mäkelä M. J., Lund G. A., Salmi A. A. 1989; Antigenicity of the measles virus haemagglutinin studied by using synthetic peptides. Journal of General Virology 70:603–614
    [Google Scholar]
  12. Nishikawa K., Morishima T., Toyoda T., Miyadai T., Yokochi T., Yoshida T., Nagai Y. 1986; Topological and operational delineation of antigenic sites on the HN glycoprotein of Newcastle disease virus and their structural requirements. Journal of Virology 60:987–993
    [Google Scholar]
  13. Norrby E., Utter G., örvell C., Appel M. J. G. 1986; Protection against canine distemper virus in dogs after immunization with isolated fusion protein. Journal of Virology 58:536–541
    [Google Scholar]
  14. Örvell C., Sheshberadaran H., Norrby E. 1985; Preparation and characterization of monoclonal antibodies directed against four structural components of canine distemper virus. Journal of General Virology 66:443–156
    [Google Scholar]
  15. Plowright W., Ferris R. D. 1959; Studies with rinderpest virus in tissue culture. II. Pathogenicity for cattle of culture-passaged virus. Journal of Comparative Pathology and Therapeutics 69:173–184
    [Google Scholar]
  16. Plowright W., Ferris R. D. 1962; Studies with rinderpest virus in tissue culture. The use of attenuated culture virus as a vaccine for cattle. Research in Veterinary Science 3:172–182
    [Google Scholar]
  17. Rima B. K. 1989; Comparison of amino acid sequences of the major structural proteins of the paramyxo- and morbilliviruses. In Genetics and Pathogenicity of Negative Strand Viruses pp. 256–263 Edited by Kolakofsky D., Mahy B. W. J. Amsterdam: Elsevier;
    [Google Scholar]
  18. Sato T. A., Fukuda A., Sugiura A. 1985; Characterization of major structural proteins of measles virus with monoclonal antibodies. Journal of General Virology 66:1397–1409
    [Google Scholar]
  19. Scheid A., Caliguiri L. A., Compans R. W., Choppin P. W. 1972; Isolation of paramyxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein. Virology 50:640–651
    [Google Scholar]
  20. Sheshberadaran H., Norrby E., McCullough K. C., Carpenter W. C., Örvell C. 1986; The antigenic relationship between measles, canine distemper and rinderpest viruses studied with monoclonal antibodies. Journal of General Virology 67:1381–1392
    [Google Scholar]
  21. Sugiyama M., Minamoto N., Kinjo T., Hirayama N., Sasaki H., Yoshikawa Y., Yamanouchi K. 1989; Characterization of monoclonal antibodies against four structural proteins of rinderpest virus. Journal of General Virology 70:2605–2613
    [Google Scholar]
  22. Tsukiyama K., Sugiyama M., Yoshikawa Y., Yamanouchi K. 1987; Molecular cloning and sequence analysis of the rinderpest virus mRNA encoding the hemagglutinin protein. Virology 160:48–54
    [Google Scholar]
  23. Tsukiyama K., Yoshikawa Y., Yamanouchi K. 1988; Fusion glycoprotein (F) of rinderpest virus: entire nucleotide sequence of the F mRNA, and several features of the F protein. Virology 164:523–530
    [Google Scholar]
  24. Tsukiyama K., Yoshikawa Y., Kamata H., Imaoka K., Asano K., Funahashi S., Maruyama T., Shida H., Sugimoto M., Yamanouchi K. 1989; Development of heat-stable recombinant rinderpest vaccine. Archives of Virology 107:225–235
    [Google Scholar]
  25. Waterson A. P., Rott R., Ruckle-Enders G. 1963; The components of measles virus and their relation to rinderpest and distemper. Zeitschrift für Naturforschung 18b:377–384
    [Google Scholar]
  26. Yamanaka M., Hsu D., Crisp T., Dale B., Grubman M., Yilma T. 1988; Cloning and sequence analysis of the hemagglutinin gene of the virulent strain of rinderpest virus. Virology 166:251–253
    [Google Scholar]
  27. Yilma T., Hsu D., Jones L., Owens S., Grubman M., Mebus C., Yamanaka M., Dale B. 1988; Protection of cattle against rinderpest with vaccinia virus recombinants expressing the HA or F gene. Science 2421058–1061
    [Google Scholar]
/content/journal/jgv/10.1099/0022-1317-72-8-1863
Loading
/content/journal/jgv/10.1099/0022-1317-72-8-1863
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error